Total Funding
44
73
Total FundingSeries B raised
Growth Score
-1 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
51089
Onconic Therapeutics specialises in the research and development of cancer treatments.
- John Kim: CEO
Jongkil Shin: CFOPast Role: Jeil Pharmaceutical, Executive Director
About the Company
Onconic Therapeutics is a biopharmaceutical company engaged in the research and development of novel therapeutics for gastrointestinal disorders and oncology indications with significant unmet medical needs. Its pipeline includes Zataprazan (OCN-101) and OCN-201. The company specializes in innovative cancer treatment research and drug discovery.
